Taisho Pharmaceutical Holdings Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Stock Competitors & Peer Comparison
See (TAIPY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| MKGAF | $145.78 | -3.40% | 66.6B | 19.02 | $8.05 | +1.63% |
| MKKGY | $29.90 | +0.67% | 65B | 18.56 | $1.61 | +1.67% |
| IPSEY | $46.15 | +0.00% | 61B | 29.02 | $1.59 | +0.86% |
| TKPHF | $37.00 | +0.00% | 58.4B | 80.43 | $0.46 | +3.57% |
| HLNCF | $5.03 | -7.62% | 46.5B | 22.70 | $0.23 | +1.75% |
| SDZNY | $93.31 | +9.91% | 40.2B | 179.65 | $0.52 | +0.78% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $25.94 | -0.23% | 22.1B | 20.27 | $1.28 | +1.70% |
| SGIOY | $11.81 | +1.03% | 20.1B | 17.88 | $0.66 | +1.71% |
Stock Comparison
TAIPY vs MKGAF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, MKGAF has a market cap of 66.6B. Regarding current trading prices, TAIPY is priced at $14.00, while MKGAF trades at $145.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas MKGAF's P/E ratio is 19.02. In terms of profitability, TAIPY's ROE is +0.02%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, TAIPY is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check MKGAF's competition here
TAIPY vs MKKGY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, MKKGY has a market cap of 65B. Regarding current trading prices, TAIPY is priced at $14.00, while MKKGY trades at $29.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas MKKGY's P/E ratio is 18.56. In terms of profitability, TAIPY's ROE is +0.02%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, TAIPY is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check MKKGY's competition here
TAIPY vs IPSEY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, IPSEY has a market cap of 61B. Regarding current trading prices, TAIPY is priced at $14.00, while IPSEY trades at $46.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas IPSEY's P/E ratio is 29.02. In terms of profitability, TAIPY's ROE is +0.02%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, TAIPY is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check IPSEY's competition here
TAIPY vs TKPHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, TKPHF has a market cap of 58.4B. Regarding current trading prices, TAIPY is priced at $14.00, while TKPHF trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas TKPHF's P/E ratio is 80.43. In terms of profitability, TAIPY's ROE is +0.02%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, TAIPY is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check TKPHF's competition here
TAIPY vs HLNCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HLNCF has a market cap of 46.5B. Regarding current trading prices, TAIPY is priced at $14.00, while HLNCF trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HLNCF's P/E ratio is 22.70. In terms of profitability, TAIPY's ROE is +0.02%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, TAIPY is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HLNCF's competition here
TAIPY vs SDZNY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SDZNY has a market cap of 40.2B. Regarding current trading prices, TAIPY is priced at $14.00, while SDZNY trades at $93.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SDZNY's P/E ratio is 179.65. In terms of profitability, TAIPY's ROE is +0.02%, compared to SDZNY's ROE of +0.02%. Regarding short-term risk, TAIPY is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SDZNY's competition here
TAIPY vs TEVJF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, TAIPY is priced at $14.00, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, TAIPY's ROE is +0.02%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, TAIPY is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check TEVJF's competition here
TAIPY vs SGIOF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SGIOF has a market cap of 22.1B. Regarding current trading prices, TAIPY is priced at $14.00, while SGIOF trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SGIOF's P/E ratio is 20.27. In terms of profitability, TAIPY's ROE is +0.02%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, TAIPY is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SGIOF's competition here
TAIPY vs SGIOY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SGIOY has a market cap of 20.1B. Regarding current trading prices, TAIPY is priced at $14.00, while SGIOY trades at $11.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SGIOY's P/E ratio is 17.88. In terms of profitability, TAIPY's ROE is +0.02%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, TAIPY is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SGIOY's competition here
TAIPY vs ESALY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, TAIPY is priced at $14.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ESALY's P/E ratio is 20.54. In terms of profitability, TAIPY's ROE is +0.02%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, TAIPY is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ESALY's competition here
TAIPY vs BIOVF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, BIOVF has a market cap of 12.8B. Regarding current trading prices, TAIPY is priced at $14.00, while BIOVF trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas BIOVF's P/E ratio is 246.67. In terms of profitability, TAIPY's ROE is +0.02%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, TAIPY is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check BIOVF's competition here
TAIPY vs ESAIY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ESAIY has a market cap of 9.4B. Regarding current trading prices, TAIPY is priced at $14.00, while ESAIY trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ESAIY's P/E ratio is 29.50. In terms of profitability, TAIPY's ROE is +0.02%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, TAIPY is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ESAIY's competition here
TAIPY vs IPSEF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, TAIPY is priced at $14.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, TAIPY's ROE is +0.02%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, TAIPY is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check IPSEF's competition here
TAIPY vs ESALF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ESALF has a market cap of 9.3B. Regarding current trading prices, TAIPY is priced at $14.00, while ESALF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ESALF's P/E ratio is 28.95. In terms of profitability, TAIPY's ROE is +0.02%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, TAIPY is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ESALF's competition here
TAIPY vs SFOSF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, TAIPY is priced at $14.00, while SFOSF trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SFOSF's P/E ratio is 14.50. In terms of profitability, TAIPY's ROE is +0.02%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, TAIPY is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SFOSF's competition here
TAIPY vs SMDPY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SMDPY has a market cap of 6.1B. Regarding current trading prices, TAIPY is priced at $14.00, while SMDPY trades at $15.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SMDPY's P/E ratio is 6.02. In terms of profitability, TAIPY's ROE is +0.02%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, TAIPY is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SMDPY's competition here
TAIPY vs LVZPF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, TAIPY is priced at $14.00, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, TAIPY's ROE is +0.02%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, TAIPY is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check LVZPF's competition here
TAIPY vs GZPHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, TAIPY is priced at $14.00, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, TAIPY is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check GZPHF's competition here
TAIPY vs DNPUF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, DNPUF has a market cap of 5.9B. Regarding current trading prices, TAIPY is priced at $14.00, while DNPUF trades at $14.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas DNPUF's P/E ratio is 5.81. In terms of profitability, TAIPY's ROE is +0.02%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, TAIPY is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check DNPUF's competition here
TAIPY vs HLUBF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, TAIPY is priced at $14.00, while HLUBF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HLUBF's P/E ratio is 11.43. In terms of profitability, TAIPY's ROE is +0.02%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, TAIPY is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HLUBF's competition here
TAIPY vs HKMPY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HKMPY has a market cap of 5B. Regarding current trading prices, TAIPY is priced at $14.00, while HKMPY trades at $45.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HKMPY's P/E ratio is 13.49. In terms of profitability, TAIPY's ROE is +0.02%, compared to HKMPY's ROE of +0.15%. Regarding short-term risk, TAIPY is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HKMPY's competition here
TAIPY vs HLBBF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HLBBF has a market cap of 4.9B. Regarding current trading prices, TAIPY is priced at $14.00, while HLBBF trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HLBBF's P/E ratio is 12.17. In terms of profitability, TAIPY's ROE is +0.02%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, TAIPY is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HLBBF's competition here
TAIPY vs HKMPF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HKMPF has a market cap of 4.8B. Regarding current trading prices, TAIPY is priced at $14.00, while HKMPF trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HKMPF's P/E ratio is 13.14. In terms of profitability, TAIPY's ROE is +0.02%, compared to HKMPF's ROE of +0.15%. Regarding short-term risk, TAIPY is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HKMPF's competition here
TAIPY vs SGFEF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SGFEF has a market cap of 4.6B. Regarding current trading prices, TAIPY is priced at $14.00, while SGFEF trades at $104.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SGFEF's P/E ratio is 23.51. In terms of profitability, TAIPY's ROE is +0.02%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, TAIPY is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SGFEF's competition here
TAIPY vs APNHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, TAIPY is priced at $14.00, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas APNHF's P/E ratio is -54.67. In terms of profitability, TAIPY's ROE is +0.02%, compared to APNHF's ROE of -0.01%. Regarding short-term risk, TAIPY is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check APNHF's competition here
TAIPY vs APNHY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, APNHY has a market cap of 3.6B. Regarding current trading prices, TAIPY is priced at $14.00, while APNHY trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas APNHY's P/E ratio is -53.67. In terms of profitability, TAIPY's ROE is +0.02%, compared to APNHY's ROE of -0.01%. Regarding short-term risk, TAIPY is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check APNHY's competition here
TAIPY vs LBTSF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, TAIPY is priced at $14.00, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas LBTSF's P/E ratio is 66.74. In terms of profitability, TAIPY's ROE is +0.02%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, TAIPY is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check LBTSF's competition here
TAIPY vs CHSYF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, TAIPY is priced at $14.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, TAIPY's ROE is +0.02%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, TAIPY is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CHSYF's competition here
TAIPY vs ULIHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, TAIPY is priced at $14.00, while ULIHF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ULIHF's P/E ratio is 6.67. In terms of profitability, TAIPY's ROE is +0.02%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, TAIPY is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ULIHF's competition here
TAIPY vs INVVY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, TAIPY is priced at $14.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas INVVY's P/E ratio is -62.42. In terms of profitability, TAIPY's ROE is +0.02%, compared to INVVY's ROE of -0.60%. Regarding short-term risk, TAIPY is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check INVVY's competition here
TAIPY vs HYPMY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, TAIPY is priced at $14.00, while HYPMY trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HYPMY's P/E ratio is 18.32. In terms of profitability, TAIPY's ROE is +0.02%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, TAIPY is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HYPMY's competition here
TAIPY vs IZQVF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, TAIPY is priced at $14.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, TAIPY's ROE is +0.02%, compared to IZQVF's ROE of -0.60%. Regarding short-term risk, TAIPY is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check IZQVF's competition here
TAIPY vs HMDCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HMDCF has a market cap of 2.6B. Regarding current trading prices, TAIPY is priced at $14.00, while HMDCF trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HMDCF's P/E ratio is 5.70. In terms of profitability, TAIPY's ROE is +0.02%, compared to HMDCF's ROE of +0.47%. Regarding short-term risk, TAIPY is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HMDCF's competition here
TAIPY vs NPPNY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, TAIPY is priced at $14.00, while NPPNY trades at $8.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas NPPNY's P/E ratio is 10.92. In terms of profitability, TAIPY's ROE is +0.02%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, TAIPY is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check NPPNY's competition here
TAIPY vs DMPHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, TAIPY is priced at $14.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, TAIPY's ROE is +0.02%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, TAIPY is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check DMPHF's competition here
TAIPY vs NPNKF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, TAIPY is priced at $14.00, while NPNKF trades at $30.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas NPNKF's P/E ratio is 9.94. In terms of profitability, TAIPY's ROE is +0.02%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, TAIPY is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check NPNKF's competition here
TAIPY vs HTSUF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, TAIPY is priced at $14.00, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, TAIPY's ROE is +0.02%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, TAIPY is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HTSUF's competition here
TAIPY vs ARSUF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, TAIPY is priced at $14.00, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ARSUF's P/E ratio is 19.42. In terms of profitability, TAIPY's ROE is +0.02%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, TAIPY is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ARSUF's competition here
TAIPY vs CURLF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CURLF has a market cap of 1.9B. Regarding current trading prices, TAIPY is priced at $14.00, while CURLF trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CURLF's P/E ratio is -6.97. In terms of profitability, TAIPY's ROE is +0.02%, compared to CURLF's ROE of -0.31%. Regarding short-term risk, TAIPY is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CURLF's competition here
TAIPY vs DUTV Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, TAIPY is priced at $14.00, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas DUTV's P/E ratio is N/A. In terms of profitability, TAIPY's ROE is +0.02%, compared to DUTV's ROE of -0.05%. Regarding short-term risk, TAIPY is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for TAIPY.Check DUTV's competition here
TAIPY vs TSMRF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, TAIPY is priced at $14.00, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, TAIPY's ROE is +0.02%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, TAIPY is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check TSMRF's competition here
TAIPY vs MITPF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, TAIPY is priced at $14.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas MITPF's P/E ratio is -10.81. In terms of profitability, TAIPY's ROE is +0.02%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, TAIPY is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for TAIPY.Check MITPF's competition here
TAIPY vs SHPHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SHPHF has a market cap of 1.6B. Regarding current trading prices, TAIPY is priced at $14.00, while SHPHF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SHPHF's P/E ratio is -5.67. In terms of profitability, TAIPY's ROE is +0.02%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, TAIPY is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SHPHF's competition here
TAIPY vs GTBIF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, GTBIF has a market cap of 1.5B. Regarding current trading prices, TAIPY is priced at $14.00, while GTBIF trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas GTBIF's P/E ratio is 38.71. In terms of profitability, TAIPY's ROE is +0.02%, compared to GTBIF's ROE of +0.02%. Regarding short-term risk, TAIPY is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check GTBIF's competition here
TAIPY vs KARBF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, TAIPY is priced at $14.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas KARBF's P/E ratio is 262.50. In terms of profitability, TAIPY's ROE is +0.02%, compared to KARBF's ROE of N/A. Regarding short-term risk, TAIPY is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check KARBF's competition here
TAIPY vs EVOTF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, EVOTF has a market cap of 1.4B. Regarding current trading prices, TAIPY is priced at $14.00, while EVOTF trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas EVOTF's P/E ratio is -7.42. In terms of profitability, TAIPY's ROE is +0.02%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, TAIPY is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check EVOTF's competition here
TAIPY vs CHIZF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, TAIPY is priced at $14.00, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, TAIPY's ROE is +0.02%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, TAIPY is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CHIZF's competition here
TAIPY vs SWGHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, TAIPY is priced at $14.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, TAIPY's ROE is +0.02%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, TAIPY is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SWGHF's competition here
TAIPY vs CASBF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, TAIPY is priced at $14.00, while CASBF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CASBF's P/E ratio is -37.50. In terms of profitability, TAIPY's ROE is +0.02%, compared to CASBF's ROE of -0.03%. Regarding short-term risk, TAIPY is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CASBF's competition here
TAIPY vs TCNNF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, TAIPY is priced at $14.00, while TCNNF trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas TCNNF's P/E ratio is -10.40. In terms of profitability, TAIPY's ROE is +0.02%, compared to TCNNF's ROE of -0.11%. Regarding short-term risk, TAIPY is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check TCNNF's competition here
TAIPY vs LJUIF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, TAIPY is priced at $14.00, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, TAIPY's ROE is +0.02%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, TAIPY is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check LJUIF's competition here
TAIPY vs KSPHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, TAIPY is priced at $14.00, while KSPHF trades at $26.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas KSPHF's P/E ratio is 12.04. In terms of profitability, TAIPY's ROE is +0.02%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, TAIPY is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check KSPHF's competition here
TAIPY vs BIOGY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, TAIPY is priced at $14.00, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, TAIPY's ROE is +0.02%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, TAIPY is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check BIOGY's competition here
TAIPY vs GNMLF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, GNMLF has a market cap of 1B. Regarding current trading prices, TAIPY is priced at $14.00, while GNMLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas GNMLF's P/E ratio is 10.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to GNMLF's ROE of +0.13%. Regarding short-term risk, TAIPY is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check GNMLF's competition here
TAIPY vs KKPCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, TAIPY is priced at $14.00, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, TAIPY's ROE is +0.02%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, TAIPY is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check KKPCF's competition here
TAIPY vs TWAPF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, TAIPY is priced at $14.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, TAIPY's ROE is +0.02%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, TAIPY is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check TWAPF's competition here
TAIPY vs NIKA Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, TAIPY is priced at $14.00, while NIKA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas NIKA's P/E ratio is N/A. In terms of profitability, TAIPY's ROE is +0.02%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, TAIPY is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check NIKA's competition here
TAIPY vs CSWYF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, TAIPY is priced at $14.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, TAIPY's ROE is +0.02%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, TAIPY is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CSWYF's competition here
TAIPY vs TRXPF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, TAIPY is priced at $14.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, TAIPY's ROE is +0.02%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, TAIPY is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check TRXPF's competition here
TAIPY vs SHEZF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, TAIPY is priced at $14.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, TAIPY's ROE is +0.02%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, TAIPY is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SHEZF's competition here
TAIPY vs YIHCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, TAIPY is priced at $14.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, TAIPY is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check YIHCF's competition here
TAIPY vs GLASF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, GLASF has a market cap of 638.1M. Regarding current trading prices, TAIPY is priced at $14.00, while GLASF trades at $8.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas GLASF's P/E ratio is -39.32. In terms of profitability, TAIPY's ROE is +0.02%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, TAIPY is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check GLASF's competition here
TAIPY vs AIHLF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, TAIPY is priced at $14.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, TAIPY's ROE is +0.02%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, TAIPY is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check AIHLF's competition here
TAIPY vs TRSSF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, TAIPY is priced at $14.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, TAIPY's ROE is +0.02%, compared to TRSSF's ROE of -0.85%. Regarding short-term risk, TAIPY is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check TRSSF's competition here
TAIPY vs PKBFF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, TAIPY is priced at $14.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas PKBFF's P/E ratio is N/A. In terms of profitability, TAIPY's ROE is +0.02%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, TAIPY is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check PKBFF's competition here
TAIPY vs CCHWF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, TAIPY is priced at $14.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, TAIPY's ROE is +0.02%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, TAIPY is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for TAIPY.Check CCHWF's competition here
TAIPY vs BOIRF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, TAIPY is priced at $14.00, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, TAIPY's ROE is +0.02%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, TAIPY is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check BOIRF's competition here
TAIPY vs AGYTF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, TAIPY is priced at $14.00, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, TAIPY is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check AGYTF's competition here
TAIPY vs KHTRF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, KHTRF has a market cap of 474.3M. Regarding current trading prices, TAIPY is priced at $14.00, while KHTRF trades at $4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas KHTRF's P/E ratio is -157.43. In terms of profitability, TAIPY's ROE is +0.02%, compared to KHTRF's ROE of -0.00%. Regarding short-term risk, TAIPY is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check KHTRF's competition here
TAIPY vs PEXXF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, TAIPY is priced at $14.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to PEXXF's ROE of N/A. Regarding short-term risk, TAIPY is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check PEXXF's competition here
TAIPY vs SWDCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SWDCF has a market cap of 443.7M. Regarding current trading prices, TAIPY is priced at $14.00, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SWDCF's P/E ratio is 69.40. In terms of profitability, TAIPY's ROE is +0.02%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, TAIPY is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SWDCF's competition here
TAIPY vs VRNOF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, VRNOF has a market cap of 437.8M. Regarding current trading prices, TAIPY is priced at $14.00, while VRNOF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas VRNOF's P/E ratio is -1.22. In terms of profitability, TAIPY's ROE is +0.02%, compared to VRNOF's ROE of -0.52%. Regarding short-term risk, TAIPY is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for TAIPY.Check VRNOF's competition here
TAIPY vs ELTP Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ELTP has a market cap of 435.2M. Regarding current trading prices, TAIPY is priced at $14.00, while ELTP trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ELTP's P/E ratio is 20.25. In terms of profitability, TAIPY's ROE is +0.02%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, TAIPY is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ELTP's competition here
TAIPY vs HUMDF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HUMDF has a market cap of 405.4M. Regarding current trading prices, TAIPY is priced at $14.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HUMDF's P/E ratio is 2.74. In terms of profitability, TAIPY's ROE is +0.02%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, TAIPY is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HUMDF's competition here
TAIPY vs CRLBF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CRLBF has a market cap of 350.7M. Regarding current trading prices, TAIPY is priced at $14.00, while CRLBF trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CRLBF's P/E ratio is -6.44. In terms of profitability, TAIPY's ROE is +0.02%, compared to CRLBF's ROE of -0.12%. Regarding short-term risk, TAIPY is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CRLBF's competition here
TAIPY vs CPHRF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CPHRF has a market cap of 287.8M. Regarding current trading prices, TAIPY is priced at $14.00, while CPHRF trades at $11.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CPHRF's P/E ratio is 16.93. In terms of profitability, TAIPY's ROE is +0.02%, compared to CPHRF's ROE of +0.16%. Regarding short-term risk, TAIPY is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CPHRF's competition here
TAIPY vs BHCCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, TAIPY is priced at $14.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, TAIPY's ROE is +0.02%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, TAIPY is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check BHCCF's competition here
TAIPY vs PLNHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, TAIPY is priced at $14.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, TAIPY's ROE is +0.02%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, TAIPY is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check PLNHF's competition here
TAIPY vs PHCUF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, TAIPY is priced at $14.00, while PHCUF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas PHCUF's P/E ratio is 700.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, TAIPY is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check PHCUF's competition here
TAIPY vs SHIEF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, TAIPY is priced at $14.00, while SHIEF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, TAIPY's ROE is +0.02%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, TAIPY is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check SHIEF's competition here
TAIPY vs COPHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, TAIPY is priced at $14.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas COPHF's P/E ratio is -0.02. In terms of profitability, TAIPY's ROE is +0.02%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, TAIPY is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TAIPY.Check COPHF's competition here
TAIPY vs BIOYF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, BIOYF has a market cap of 130.3M. Regarding current trading prices, TAIPY is priced at $14.00, while BIOYF trades at $11.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas BIOYF's P/E ratio is 21.03. In terms of profitability, TAIPY's ROE is +0.02%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, TAIPY is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check BIOYF's competition here
TAIPY vs LOVFF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, LOVFF has a market cap of 125.5M. Regarding current trading prices, TAIPY is priced at $14.00, while LOVFF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas LOVFF's P/E ratio is 14.56. In terms of profitability, TAIPY's ROE is +0.02%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, TAIPY is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check LOVFF's competition here
TAIPY vs NWPN Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, TAIPY is priced at $14.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas NWPN's P/E ratio is -0.04. In terms of profitability, TAIPY's ROE is +0.02%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, TAIPY is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for TAIPY.Check NWPN's competition here
TAIPY vs CBWTF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CBWTF has a market cap of 121.4M. Regarding current trading prices, TAIPY is priced at $14.00, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CBWTF's P/E ratio is 3.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, TAIPY is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CBWTF's competition here
TAIPY vs CWBHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CWBHF has a market cap of 115.6M. Regarding current trading prices, TAIPY is priced at $14.00, while CWBHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CWBHF's P/E ratio is -5.18. In terms of profitability, TAIPY's ROE is +0.02%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, TAIPY is more volatile compared to CWBHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CWBHF's competition here
TAIPY vs AAWH Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, AAWH has a market cap of 114.1M. Regarding current trading prices, TAIPY is priced at $14.00, while AAWH trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas AAWH's P/E ratio is -1.34. In terms of profitability, TAIPY's ROE is +0.02%, compared to AAWH's ROE of -2.27%. Regarding short-term risk, TAIPY is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check AAWH's competition here
TAIPY vs LPCUF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, TAIPY is priced at $14.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, TAIPY's ROE is +0.02%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, TAIPY is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check LPCUF's competition here
TAIPY vs ORXOF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ORXOF has a market cap of 111.5M. Regarding current trading prices, TAIPY is priced at $14.00, while ORXOF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ORXOF's P/E ratio is -2.50. In terms of profitability, TAIPY's ROE is +0.02%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, TAIPY is more volatile compared to ORXOF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ORXOF's competition here
TAIPY vs CNVCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, TAIPY is priced at $14.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, TAIPY is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check CNVCF's competition here
TAIPY vs HLTRF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, HLTRF has a market cap of 105.1M. Regarding current trading prices, TAIPY is priced at $14.00, while HLTRF trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas HLTRF's P/E ratio is -7.47. In terms of profitability, TAIPY's ROE is +0.02%, compared to HLTRF's ROE of -0.21%. Regarding short-term risk, TAIPY is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check HLTRF's competition here
TAIPY vs JUSHF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, JUSHF has a market cap of 105M. Regarding current trading prices, TAIPY is priced at $14.00, while JUSHF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas JUSHF's P/E ratio is -1.62. In terms of profitability, TAIPY's ROE is +0.02%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, TAIPY is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check JUSHF's competition here
TAIPY vs ORXOY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ORXOY has a market cap of 102.7M. Regarding current trading prices, TAIPY is priced at $14.00, while ORXOY trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ORXOY's P/E ratio is -2.29. In terms of profitability, TAIPY's ROE is +0.02%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, TAIPY is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ORXOY's competition here
TAIPY vs ABSCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, TAIPY is priced at $14.00, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas ABSCF's P/E ratio is -8.06. In terms of profitability, TAIPY's ROE is +0.02%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, TAIPY is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check ABSCF's competition here
TAIPY vs GRUSF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, GRUSF has a market cap of 89.8M. Regarding current trading prices, TAIPY is priced at $14.00, while GRUSF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas GRUSF's P/E ratio is 12.00. In terms of profitability, TAIPY's ROE is +0.02%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, TAIPY is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check GRUSF's competition here
TAIPY vs EOFBY Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, TAIPY is priced at $14.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, TAIPY's ROE is +0.02%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, TAIPY is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check EOFBY's competition here
TAIPY vs MEDXF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, MEDXF has a market cap of 68.3M. Regarding current trading prices, TAIPY is priced at $14.00, while MEDXF trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas MEDXF's P/E ratio is -105.67. In terms of profitability, TAIPY's ROE is +0.02%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, TAIPY is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check MEDXF's competition here
TAIPY vs GDNSF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, TAIPY is priced at $14.00, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, TAIPY's ROE is +0.02%, compared to GDNSF's ROE of -0.24%. Regarding short-term risk, TAIPY is more volatile compared to GDNSF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check GDNSF's competition here
TAIPY vs PROCF Comparison February 2026
TAIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TAIPY stands at 18.1B. In comparison, PROCF has a market cap of 55.8M. Regarding current trading prices, TAIPY is priced at $14.00, while PROCF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TAIPY currently has a P/E ratio of 82.35, whereas PROCF's P/E ratio is 0.06. In terms of profitability, TAIPY's ROE is +0.02%, compared to PROCF's ROE of -2.24%. Regarding short-term risk, TAIPY is more volatile compared to PROCF. This indicates potentially higher risk in terms of short-term price fluctuations for TAIPY.Check PROCF's competition here